Centerbridge Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,222,931
Closed -$182M 40
2021
Q4
$182M Hold
2,222,931
10.36% 3
2021
Q3
$148M Buy
2,222,931
+77,284
+4% +$5.48M 17.26% 3
2021
Q2
$144M Buy
2,145,647
+62,274
+3% +$3.86M 13.15% 3
2021
Q1
$108M Buy
+2,083,373
New +$105M 10.07% 3

Other funds holding THC

Centerbridge Partners's THC Position: Q1 2022 in Review

Centerbridge Partners sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 2,222,931 shares — an estimated $182M sold.

Centerbridge Partners first reported a position in THC in Q1 2021 and held it in 4 quarters. The position peaked at $182M in Q4 2021. 404 funds tracked by Wall St. Rank hold THC as of Q1 2022.

  • Centerbridge Partners reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
  • Centerbridge Partners sold 2,222,931 Tenet Healthcare shares in Q1 2022, an estimated $182M.
  • Centerbridge Partners first reported a position in Tenet Healthcare in Q1 2021 and held it in 4 quarters.
  • Centerbridge Partners's Tenet Healthcare position peaked at $182M in Q4 2021.
  • 404 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Centerbridge Partners's 13F filing for Q1 2022, filed 16 May 2022.